Join
Live feed
·
INSIDERFilingvia Quantisnow
Recro Pharma Inc. logo

SEC Form 4: Miller James Charles bought $15,000 worth of shares (37,500 units at $0.40), increasing direct ownership by 20% to 227,543 units

ByQuantisnow·Wall Street's wire, on your screen.
REPH· Recro Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REPH (Recro Pharma Inc.) and more on Quantisnow.